Back to AQR CAPITAL MANAGEMENT LLC AQR CAPITAL MANAGEMENT LLC

ARWRARWR
Showing 6 of 24 quarters

Position history for AQR CAPITAL MANAGEMENT LLCAQR CAPITAL MANAGEMENT LLC's holdings in ARROWHEAD PHARMACEUTICALS IN

AQR CAPITAL MANAGEMENT LLC holds 198,842 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $15.8M as of 2026-Q2. The position was increased (+18.9% shares). ARWR represents 0.0% of AQR CAPITAL MANAGEMENT LLC's portfolio.

Current Value

$15.8M

Current Shares

198,842

Total Value Change

+$15.3M

Total Shares Change

+158,336

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
198,842
+18.9%
$15.8M0.0%$81.51
33
2026-Q1
Increased
167,210
+13.5%
$10.3M0.0%$64.10
31
2025-Q4
Increased
147,353
+3.2%
$9.8M0.0%$67.25
29
2025-Q3
Decreased
142,825
-6.3%
$4.9M0.0%$33.78
0
2025-Q2
Increased
152,351
+276.1%
$2.4M0.0%$16.08
42
2025-Q1
New
40,506
-
$513,6160.0%$13.82
33

Other major holders of ARWR: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used